Fda accepts evinacumab biologics license application for priority review as a treatment for patients with hofh, an ultra-rare inherited form of high cholesterol

Tarrytown, n.y., aug. 12, 2020 /prnewswire/ -- homozygous familial hypercholesterolemia affects approximately 1,300 patients in the u.s.

REGN Ratings Summary

REGN Quant Ranking